- Home
- VRNA vs PII Comparison
VRNA vs PII Comparison
Compare VRNA & PII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- PII
- Stock Information
- Founded
- VRNA 2005
- PII 1954
- Country
- VRNA United Kingdom
- PII United States
- Employees
- VRNA N/A
- PII N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- PII Recreational Games/Products/Toys
- Sector
- VRNA Health Care
- PII Consumer Discretionary
- Exchange
- VRNA Nasdaq
- PII Nasdaq
- Market Cap
- VRNA 3.2B
- PII 3.8B
- IPO Year
- VRNA 2017
- PII 1987
- Fundamental
- Price
- VRNA $41.66
- PII $60.75
- Analyst Decision
- VRNA Strong Buy
- PII Buy
- Analyst Count
- VRNA 6
- PII 12
- Target Price
- VRNA $43.83
- PII $85.00
- AVG Volume (30 Days)
- VRNA 1.0M
- PII 814.1K
- Earning Date
- VRNA 11-04-2024
- PII 01-28-2025
- Dividend Yield
- VRNA N/A
- PII 4.38%
- EPS Growth
- VRNA N/A
- PII N/A
- EPS
- VRNA N/A
- PII 3.57
- Revenue
- VRNA $5,624,000.00
- PII $7,803,200,000.00
- Revenue This Year
- VRNA N/A
- PII N/A
- Revenue Next Year
- VRNA $644.06
- PII $1.03
- P/E Ratio
- VRNA N/A
- PII $17.04
- Revenue Growth
- VRNA 1127.95
- PII N/A
- 52 Week Low
- VRNA $11.39
- PII $60.25
- 52 Week High
- VRNA $43.73
- PII $100.91
- Technical
- Relative Strength Index (RSI)
- VRNA 61.99
- PII 31.01
- Support Level
- VRNA $38.77
- PII $63.23
- Resistance Level
- VRNA $43.73
- PII $67.51
- Average True Range (ATR)
- VRNA 1.41
- PII 2.20
- MACD
- VRNA 0.07
- PII -0.27
- Stochastic Oscillator
- VRNA 60.80
- PII 7.19
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About PII Polaris Inc.
Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products retailed through more than 2,500 dealers in North America and through 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.